Articles tagged with Viral Infections
Researchers have found that Zika virus alters the expression of hundreds of genes responsible for guiding brain cell formation, leading to microcephaly. The study reveals new therapeutic targets by analyzing molecular interactions in infected brain cells.
Researchers at UC San Diego are working on developing new treatments for Zika virus infections and ovarian cancer using stem cell-derived natural killer cells. They have already reported promising results, suggesting that some FDA-approved drugs may be effective against the virus.
Scientists have identified a 'molecular barcode' in blood samples from Ebola patients that can predict survival or death. The analysis provides data on the underlying causes of Ebola virus infection and suggests a potential diagnostic tool to guide treatment strategies.
H5Nx viruses, spreading globally through migratory wild birds, display a binding protein on their surfaces that allows them to exit host cells. This adaptation may render them less able to spread to humans, but not rule out eventual evolution to infect people.
Researchers at UM SOM and SOD published 22 articles on infectious agents, vaccines, and immune system activation. Studies focused on Ebola, Clostridium difficile, biofilms, and other topics, advancing knowledge in infection and immunity research.
Researchers have identified nanchangmycin as a potent inhibitor of Zika virus entry into human cells, including endothelial and placental cells. This finding represents a 'stepping stone' towards the development of a new class of anti-virals that target the same mode of entry used by other viruses like West Nile and dengue.
Researchers have discovered that plant-derived products, such as proanthocyanidin (PAC), can inhibit hepatitis B virus (HBV) entry into host cells and potentially treat treatment-resistant strains. PAC also enhances the effectiveness of antiviral drugs like tenofovir, offering a promising new approach to combatting HBV.
Researchers used a new mouse model to study how the Ebola virus affects the immune system, focusing on cellular signaling events. They found that macrophages play a critical role in controlling EBOV infection by producing MAVS, which helps limit organ damage and promotes type I interferon production.
Researchers found that bacteria alters molecules in a tick's gut, allowing it to enter and colonize the gut microbes. This finding could help scientists develop strategies to block tick-borne agents causing disease.
A team of researchers has found that certain anti-influenza compounds can also inhibit Zika virus infection, providing a potential new treatment for the disease. The study, published in Antiviral Research, shows that these compounds target host cell factors, making them effective against viruses that mutate easily.
Researchers emphasize the need for continued study of Zika virus due to its serious complications and the importance of developing effective vaccines and treatments. Lessons learned from other arboviruses like West Nile and Chikungunya highlight the risks of fading interest in diseases that transition to endemicity.
Researchers have identified a new virus as the cause of congenital tremors in newborn piglets, a potentially life-threatening disease. The discovery represents a significant diagnostic breakthrough, enabling detection through molecular methods and highlighting the risk of sexual transmission.
Researchers at UC San Diego have documented how large viruses reprogram bacterial cells to resemble animal or human cells, allowing them to mass-produce new viral particles that eventually kill the infected cells. The study reveals a previously unknown mechanism of viral replication in bacteria.
Researchers at La Jolla Institute for Immunology have discovered that CD8+ T cells, a subset of killer T cells, control Zika infection and limit disease severity. The study provides a new tool to track Zika-specific T cells, which can help understand the virus's transmission and neurological complications.
Researchers genetically modified mosquitoes to resist infection from dengue virus, boosting their natural ability to fight the disease. The findings could be a prelude to developing a strategy to eliminate the threat of dengue.
A multidisciplinary team of University of Miami physicians published a case study detailing the nation's first locally-transmitted case of Zika. The study highlights the skin rash associated with the virus and its potential implications for future Zika screening and diagnoses.
A University of California, Riverside researcher is leading a team studying the life cycles of harmful viruses. The goal is to understand viral capsid dynamics to develop new approaches to curb infections.
Researchers genetically engineered Aedes aegypti mosquitoes to resist dengue fever virus by altering the JAK/STAT pathway, resulting in a 78-83% reduction in viral copies. The modified mosquitos had normal lifespans but produced fewer eggs.
Researchers discovered flaviviruses like Dengue and Zika use an unexpected mechanism to hijack human cell machinery, suppressing translation initiation while promoting viral protein synthesis. This finding may reveal new targets for designing antiviral therapies.
Researchers have found that Aravive-S6 can inhibit Zika infection of human glial cells, adding to its previously reported anticancer properties. The study suggests a potential antiviral role for the molecule in treating neurological disorders caused by the virus.
The 'test and treat' scheme aims to reduce GP consultations and antibiotic prescriptions, but lacks robust evaluation and may not be cost-effective. The NHS England plan is based on limited data from a small pilot, which raises concerns about its scalability and potential impact.
Researchers at UC Riverside have identified a novel strategy for controlling viral diseases by targeting the interaction between a viral effector protein and a host hormone. The study found that the cucumber mosaic virus manipulates plants to release odors attractive to aphids, which transmit the virus.
A new study published in Diabetologia suggests that enterovirus infections are associated with the onset of autoimmunity in children who develop type 1 diabetes. The study found a higher incidence of enterovirus infections in children with T1D compared to control children, particularly those who developed islet autoantibodies.
A widespread outbreak of RSV and HMPV in a long-term dementia care ward infected 73% of patients, emphasizing the need for improved protocols to protect vulnerable residents. The facility has since implemented active screening, efficient separation, and partnered with a private laboratory for rapid respiratory viral testing.
Scientists discovered Ebola virus RNA lingering in the lungs of a recovering patient for about five days after it cleared from blood. The findings support the possibility of active replication in the lungs, raising potential roles for lung infection in the disease's pathogenesis and transmission.
Michigan State University has secured a $1 million USAID grant to build a mosquito factory in Yucatan, Mexico, to combat the Zika virus. The project aims to use Wolbachia bacteria to reduce mosquito populations and prevent disease transmission.
Gene therapy for liver disease is advancing with the help of adeno-associated viral (AAV) vectors, offering new therapeutic possibilities. The article discusses preclinical and clinical studies that have led to a better understanding of immune responses to AAV gene therapy.
A newly discovered virus infecting the fungus that causes white-nose syndrome in bats could help scientists track its spread. The variation in the viral genome provides clues about how the disease is moving, enabling researchers to better understand its epidemiology.
A new study published in The New England Journal of Medicine found that a shortened five-day antimicrobial treatment regimen for middle ear infections in young children is less effective than the standard 10-day regimen. The study also failed to show a significant reduction in antibiotic resistance threat.
Researchers at TSRI reveal precisely how popular flu treatment Arbidol works, stopping the virus from entering host cells. The study's findings could guide the development of future broad-spectrum therapeutics against influenza virus.
Researchers found that a genetic mutation in protein NOD1 increases susceptibility to human cytomegalovirus (CMV) infection. Studies with human cells and mice showed decreased CMV replication when NOD1 was activated, suggesting a key role in controlling the virus.
Scientists found that female mice are more susceptible to vaginal Zika virus infection during a specific stage of their reproductive cycle. The study suggests that sex hormones play a role in allowing the virus to establish itself in the reproductive tract and spread beyond it.
Researchers confirm live Zika virus infects reproductive tract, replicates and causes disease in mouse models. Hormonal injection timing affects vulnerability to infection, with diestrus-infected mice showing no signs of disease despite viral persistence.
Researchers at The University of Texas Medical Branch at Galveston have developed a novel chikungunya vaccine using an insect-specific virus that doesn't affect humans. The new vaccine elicits strong immune defenses and protects mice and nonhuman primates from disease when exposed to the chikungunya virus.
A recent study published in the New England Journal of Medicine found that Zika-linked abnormalities in human fetuses are more common and severe than initially thought. Out of 125 pregnancies among Zika-infected women, 46% resulted in birth defects or fetal death, with microcephaly being only one of several complications.
Researchers have identified two neutralizing antibodies against Zika virus that exclusively target the virus, demonstrating high specificity and protecting mice from infection. These antibodies, Z23 and Z3L1, block infection by targeting the virus' envelope protein, offering potential hope for preventative and treatment approaches.
Researchers analyzed genetic sequences of the virus and found specific mutations that occurred as it crossed the Pacific Ocean, suggesting new hypotheses for its association with microcephaly and GBS. The analysis also revealed potential relationships between viral infection and severe symptoms in adults and infants.
Researchers developed algorithms to track Ebola epidemic spread, revealing that most infected individuals stayed within their districts. The study's findings suggest using this method could inform effective control measures for new emerging epidemics.
A genetic variant in the CXCL16 gene determines whether stallions become long-term carriers of equine arteritis virus. The study found that a specific allele codes for a protein that acts as an entry receptor for the virus, leading to persistence in carrier state.
Current knowledge on EVD in great apes highlights the link between ape outbreaks and human transmission through bushmeat consumption. Vaccination of wild apes could reduce both human and animal risk but feasibility is questionable due to elusive ape habitats.
A team of researchers has found a long-sought-after mechanism in human cells that creates immunity to influenza A virus, which could help treat diseases caused by viruses. The discovery builds on over 20 years of research and demonstrates the antiviral function of RNAi in humans against distinct RNA viruses.
Researchers at Harvard University and Novartis have discovered that Zika virus can infect neural progenitor cells by grabbing onto a specific protein called AXL on the cell surface. This finding contradicts previous studies suggesting that targeting the AXL protein alone could defend against the virus.
Researchers at the University of São Paulo developed a platform that analyzes clinical samples to diagnose infection by 416 viruses found in tropical regions. The tool is designed for reference laboratories and can detect pathogens with the potential to cause epidemics in humans.
The first licensed vaccine for the potentially life-threatening dengue virus is predicted to be most cost-effective and effective in reducing the burden of dengue disease in moderate-to-high impacted regions. Routine vaccination could reduce hospital rates by up to 25% in these areas.
Researchers found that myocarditis is affecting both children and adults worldwide, with men being twice as likely as women to develop severe reactions. Early diagnosis is key to preventing long-term heart damage, and new investigational therapies are soon to be tested.
Biologists observed the emergence of two distinct virus species within a month-long experiment, leveraging a harmless human virus and two types of bacteria with varying receptors. This rapid process, known as speciation, was previously challenging to study due to its slow pace.
Researchers at Kobe University developed a new method to predict congenital CMV infection in fetuses using non-invasive tests. The most effective methods are ultrasound and PCR tests for uterine cervical secretion, which can accurately identify affected infants and enable early antiviral treatment.
Researchers at Duke-NUS Medical School have discovered how the human antibody C10 prevents Zika infection by locking proteins into place, preventing viral DNA entry. Disrupting fusion with C10 may be more effective than targeting docking in preventing Zika infection.
Researchers found that tree shrews have a natural immunity to HBV, with cytokine interferon-gamma playing a key role in the activation of hepatic natural killer cells. The study also revealed the importance of extracellular vesicles in regulating innate immune responses to HBV infection.
A pioneering study of invertebrates has uncovered 1445 viruses, including several new families, revealing people have only scratched the surface of the world of viruses. The research, led by Professor Edward Holmes, suggests these viruses have been associated with invertebrates for potentially billions of years.
A team of scientists has developed a mouse model that closely mimics fetal brain abnormalities caused by the Zika virus, revealing abnormal blood vessel formation and a leaky blood-brain barrier. This finding highlights the need to understand all the effects of Zika infection if successful therapies are to be developed.
Three new studies provide insight into the effects of Zika virus on congenital brain damage in babies and adults with neurological disorders. The research highlights common CT brain findings, including decreased brain volume and calcifications, as well as MRI findings such as orbital injuries and anatomical changes in brain tissue.
Norovirus can shed for months or years, especially in immunocompromised individuals, and triggers other gut problems like IBS and IBD. Researchers discuss strategies to slow down the virus, including new vaccine approaches.
A randomized clinical trial found that long-term collaborative care and occupational therapy did not slow functional decline in persons with Alzheimer disease. The study suggests that new assistive devices, home modifications, and technologies are needed to support patients and families at home.
Researchers at UTMB have created a Zika virus replicon system that strips the virus of its infectious genes, reducing safety risks. This tool will aid in vaccine development and understanding viral replication and mutations.
Researchers found high viral infectivity rates for dengue serotypes 2 and 3 compared to strain 1. The study also showed antibodies contribute to disease severity during secondary dengue infections.
Researchers found GALV retrovirus was likely transmitted to gibbons from rodents by medical researchers working on human diseases, causing a serious outbreak in the 1960s and 1970s. No evidence of ongoing infection or threat found in current captive gibbon populations.
Researchers have developed a new mouse model that can be used to study the Zika virus and its effects on the body. The model, which employs mice with functioning immune systems, has been shown to develop symptoms of neurological disease after infection, providing valuable insights into potential treatments.
A study by CU Anschutz found that high doses of vitamin D reduce acute respiratory illness (ARI) in older nursing home residents. The findings suggest a 40% reduction in ARI among those taking higher doses of vitamin D.
Researchers at UT Austin report that conventional flu vaccines may not be effective, and a new class of antibodies could protect against multiple strains. The study discovered a new approach to identifying and quantifying antibodies in human blood, allowing for more precise understanding of vaccine efficacy.